News Focus
News Focus
Followers 92
Posts 7488
Boards Moderated 1
Alias Born 09/18/2009

Re: nort_lorfer post# 34029

Tuesday, 10/26/2021 10:37:29 AM

Tuesday, October 26, 2021 10:37:29 AM

Post# of 44331
The time frame is one of the reasons I thought we would hit that Double-oughtober target, both a UK and a US approval. I was really disappointed when UK approval wasn't announced in our Breaking News presentation.

Little guys aren't supposed to do what our management team and our drug are doing. This is a real paradigm shift.

I really hope that Clinigen comes through with significant results based on Compassionate Use. They are extremely well-positioned for lenzilumab's market penetration in Europe.

On a different, and unpopular, subject, we had Price Change Parity with CYDY at -$0.02 at 9:53 Eastern. I didn't post it because it was early, and I wanted to see if it was just noise.

But it does appear to be working with support and/or resistance at $6.58 for HGEN, and $1.49 for CYDY.

Regardless, I totally understand your frustration, and I, too, will continue to wait. I still have one small sell order placed in the low $6B market cap range. Novavax has gotten beaten up, but they're still at a $10B market cap, which is less than half of what it was after their early success was announced.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today